PERSONAL DETAIL


PROF. DR. GAN SHIAW SZE @ GAN GIN GIN

Department of Medicine
Faculty of Medicine
 
  gangg@um.edu.my
  Department of Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, MALAYSIA
 
ResearcherID Link
  http://www.researcherid.com/rid/N-7719-2018


BIBLIOMETRIC DATA


 Total Articles in Publication List  62
 Articles With Citation Data  49
 Sum of the Times Cited   326
 Average Citations per Article   6.65
 h-index   9
 Co-authors   Collaboration Network
 This information is generated from http://researcherid.com

ACADEMIC QUALIFICATION
(Qualification), (Institution).



PROFESSIONAL
(Organisation), (Role), (Year), (Level).


  • malaysian society of haematology, Active Member, 2001, (University)
  • malaysian medical association, Member, 2001 to 2018, (National)
  • academy of medicine, Member, 2001 to 2018, (National)
  • malaysian society of haematology, Honorary Secretary, 2004 to 2008, (National)
  • ANNUAL SCIENTIFIC MEETING OF MALAYSIAN SOCIETY OF HAEMATOLOGY, Organising Chairperson, 2005, (National)
  • Academy of Medicine of Malaysia, Member, 2005 to 2019, (National)
  • Malaysian Society of Haematology 6th scientific meeting, Committee Member, 2006, (National)
  • NATIONAL TRANSPLANT REGISTRY ( BLOOD AND MARROW SECTION), Panel Member, 2007 to 2018, (National)
  • American Society of Hematology, Member, 2008 to 2018, (International)
  • Malaysian society of haematology, Council Member, 2008, (National)
  • national transplant registry , Committee Member, 2012 to 2017, (University)
  • Ministry of Health; national Credentiallinh Committee, Committee Member, 2012 to 2013, (University)
  • malaysian society of haematology , Member Of The Training And Education Advisory Council, 2012, (National)
  • malaysian society of hematology, Committee Member, 2012, (National)
  • malaysian society of haematology, Committee Member, 2012, (National)
  • ministry of health, haematology drug , National Technical Committee Members, 2014 to 2016, (National)
  • national specialist register, Committee Members, 2014 to 2016, (National)
  • malaysian society of haematology , Organising Chairperson, 2014, (National)
  • Malaysian Society of Haematology, Elected Council Member, 2015, (National)
  • royal college of physician edinburg, Member, 2016 to 2018, (International)
  • Malaysian Society of Haematology, Council Member, 2016, (National)
  • Academy of medicine , Malaysia , Panel Member, 2018 to 2019, (National)
  • national transplant registry, Expert Panel Member, 2018 to 2020, (National)
  • Ministry of Health , Expert Panel Member, 2018 to 2019, (National)
  • Malaysian Society of Haematology , Members For Life, 2018, (National)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).


  • committee member , National, 01/08/2018 to 31/12/2018 (national guidelines for stem cell therapy )
  • committee member for national curriculum for clinical master of internal medicine , University Malaya, 01/04/2018 to 31/12/2018
  • internal examiner, University Malaya, 08/05/2017 to 08/05/2017
  • KKM senari ubat haematology , National, 22/08/2016 to 31/05/2018
  • Programme Coordinator, Faculty, 01/01/2016 to 31/12/2018 (haematology block chair)
  • Head Coordinator, Faculty, 01/05/2013 to 30/04/2015
  • Quality Manager, Faculty, 01/06/2012
  • Programme Coordinator, Faculty, 15/08/2011 to 31/03/2013 (system coordinator in designing new MBBS curriculum )

AREAS OF EXPERTISE
(Area).


  • General Haematology, Haematology-Oncology, Haemopoeitic Stem Cell Transplantation


RECENT SELECTED PUBLICATIONS
(Publication).


Article in Academic Journals

2018
  • Gan GG, Hue YL. Anxiety, depression and quality of life of medical students in Malaysia. Med J Malaysia (ISI-Indexed)

2017
  • Ten, L. C., Chin, Y. M., Tai, M. C., Chin, E. F. M., Lim, Y. Y., Suthandiram, S., ... & Gan, G. G. (2017). SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression. Scientific Reports, 7. (ISI-Indexed)
  • S Issaragrisil, T Cheng-Hwai , U Bunworasate, Y Su-Peng , LY Hung,GY Tee, SFA Wahid, NS Chin, T Puavilai, GG Gin, KL Piu, H Wen-Li, C Tsai-Yun, T Numbenjapon. Cyclophosphamide vs. salvage chemotherapy plus G-CSF as chemo-mobilization in Asian Patients Undergoing Autologous Hematopoietic Stem Cell Transplant. Letter to Editor. Bone Marrow Transplantation 2017 Feb;52(2):299-300. doi: 10.1038/bmt.2016.245. (ISI-Indexed)

2016
  • Bee PC, Sekaran VS, Ng RR, Kweh YT, Gan GG. (2016) The predictive value of early molecular response in chronic myeloid leukemia patients treated with imatinib in a single real-world medical centre in a developing country. Singapore Med J , http://dx.doi.org/10.11622/smedj.2016063 (ISI-Indexed)
  • DLC Ng, GG Gan, YC Leong.(2016) Quality of life among lymphoma survivors in a developing country. Supportive Care in Cancer, 24 (12): 5015-5023 (ISI-Indexed)
  • Gan GG, Hue YL, Sathar J. (2016) Factors affecting quality of life in adult patients with Thalassemia Major and Intermedia. Ann Acad Med Singapore, 45(11):520-523 (ISI-Indexed)

2015
  • GG Gan, YC Leong, PC Bee, EFM Chin, H Abdul Halim, AKH Teh. Influence of genetic polymorphisms of cytokine genes in the outcome of HLA-matched allogeneic stem cell transplantation in a South East Asian population. Cytokine (2016), pp. 55-61 DOI 10.1016/j.cyto.2015.11.022 (ISI-Indexed)
  • Sujatha S, Gan GG, Zain SM, Bee PC, Lian LH, Chang KM, Ong TC, Mohamed Z. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma. Tumour Biol. 2015 Mar;36 (3):1819-34. doi: 10.1007/s13277-014-2785- 0. (ISI-Indexed)
  • GG Gan, YC Leong, PC Bee, E Chin, AKH Teh. Complementary and alternative medicine use in patients with haematological cancers. Supportive Care in Cancer 2015 : doi 10.1007/s00520-015-2614-z (ISI-Indexed)
  • Lim YY, Chin YM, Tai MC, Fani S, Chang KM, Ong TC, Gan GG, Ng CC. (2015)Analysis of interleukin 10 promoter single nucleotide polymorphisms and risk of non- Hodgkin lymphoma in a Malaysian population. Leukemia and Lymphoma (ISI-Indexed)

2014
  • Sujatha Suthandiram, Gan Gin Gin, Shamsul Mohd Zain, Bee Ping Chong, Lian Lay Hoong, Chang Kian Meng, Ong Tee Chuan and Zahurin Mohamed. Effects of polymorphisms within the methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics 2014;15(11):1479-94 (ISI-Indexed)
  • Sujatha S, Gan GG, Zain SM, Haerian BS, Bee PC, Lian LH, Chang KM, Ong TC, Mohamed Z. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population. Journal of Human Genetics 2014 Mar 20. doi: 10.1038/jhg.2014.19. (ISI-Indexed)
  • GG Gan, R Subramaniam, PC Bee, EFM Chin, H Abdul- Halim, MC Tai. The impact of inadequate dose of rituximab in the treatment of DLBCL in Malaysian patients. Asian Pac J Cancer Prev 2014;15(4):1703-1706 (ISI-Indexed)
  • Sujatha S, Gan GG, Zain SM, Bee PC, Lian LH, Chang KM, Ong TC, Mohamed Z. Genetic polymorphisms in the one- carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma. Tumor Biology 2014; doi 10.1007/s13277-014-2785-0 (ISI-Indexed)

2013
  • Gan GG, Norfaizal AL, Bee PC, Chin EFM, Habibah AH, Goh KL. Helicobacter pylori infection in chronic immune thrombocytopenic purpura patients in Malaysia. MJM 2013;68(3):230-232 (SCOPUS-Indexed)
  • Gan GG, Subramaniam R, Lian LH, Nadarajan VS.Ethnic variation in interleukin-6-174 (G/C) polymorphim in the Malaysian populations.Balkan journal of medical genetics 2013;16(2):53-58 (ISI-Indexed)
  • Razali RM, Bee PC, Gan GG. Survey of willingness to accept chemotherapy among elderly Malaysian patients. Asian Pac J Cancer Prev 2013:14;2029-2032 (ISI-Indexed)
  • Fusarium species infection in a patient with acute lymphoblastic leukemia (ISI-Indexed)

2012
  • Bee P C, Gan G G, Tai Y T, Haris A R, Chin E, Veera S N. An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia. Sing Med J. 2012; 53(1): 57-61 (ISI-Indexed)
  • Gan GG, Lee MTM, Subramaniam R, Lu LS, Tai MC, Phipps ME. Allele and genotype frequencies of VKORC1-1639G>A polymorphisms in three ethnic groups in Malaysia. AsPac J Mol Biol Biotech 2012;20(1):19-23 (ISI-Indexed)
  • Lim WF, Muniandi L, George E, Sathar J, Teh LK, Gan GG, Lai MI. Haemoglobin stabilizing protein expression is influenced by mean haemoglobin and HbF levels in HbE/ halassemia individuals. Blood cells, molecules and disease 2012; 48(1):17-21 (ISI-Indexed)

2011
  • GG Gan,ME Phipps,MT Lee,L-S Lu,Subramaniam R,PC Bee,SH Chang. Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations. Annals of Hematology (ISI-Indexed)
  • SAM Mukari, N Ramli, SAA Edrus, M Noordin, K Rahmat, LM Looi, D Ganesan, GG Gan, CT Tan. Central nervous system intravascular lymphoma in a Malaysian. Neurology Asia 2011; 16(1): 93-95 (ISI-Indexed)
  • Bee PC, Gan GG, Sangkar VJ, Haris AR, Chin E. Quality of life after haematopoietic stem cell transplantationin a multiracial population. Med J Mal 2011; 66:451-55 (SCOPUS-Indexed)
  • V S Nadarajan, CL Phan, CH Ang, KL Liang, GG Gan Pc Bee, Z Zakaria. Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate. Int J Hematol. 2011 (ISI-Indexed)
  • Choong SS, Rosmanizam S, Ibrahim K, Gan GG, Ariffin H. development of an algorithm of satellite markers for monitoring chimerism status in post-allogeneic haematopoietic stem cell transplantation patients. Int Jnl Lab Hem. 2011;33:182-186 (ISI/SCOPUS Indexed Publication)

2010
  • Maha A, Gan GG, Koh CL.2010. Phenotype and TCR-gamma gene rearrangements in a Malaysian cohort of T-cell leukemia /lymphoma cases. Hematology 15(6):382-390 (ISI-Indexed)

2009
  • MN Fadzilah, LJ Faizatul, MS Hasibah, Sam IJ, M Kahar Bador, GG Gan, S AbuBakar .2009. Anaerobiospirillum succiniciproducens bacteraemia in a patient with acute lymphoblastic leukaemia. Journal of Medical Microbiology ;58:142-3 (ISI-Indexed)
  • Sthaneshwar P,Nadarajan V,Maniam JAS,Nordin N,Gin GG. Serum free light chains:diagnostic and prognostic values in multiple myeloma. Clinical Chemistry and laboratory Medicine 2009;47(9):1101-07 (ISI-Indexed)

2008
  • GG Gan, A Teh, LL Chan, SK Cheong, KM Chang, HM Ibrahim. 2008. Bone marrow and stem cell transplantation: Malaysian Experience. Bone Marrow Transpl. ;42: S103-105 (ISI-Indexed)
  • GG Gan, Z Zakaria, JV Sangkar, AR Haris, PC Bee, E Chin, A Teh.2008 Adult allogeneic haematopoeitic stem cell transplantation: A Single centre experience. Med J Mal ;63(4):281-287 (SCOPUS-Indexed)
  • PC Bee, G G Gan, VJ Sangkar, Haris A Rahman. 2008. Nephrotic Syndrome in a Patient with Relapsed of Chronic Myeloid Leukemia after Peripheral Blood Stem cell transplantation. Med J Mal ;63(1):71-2 (SCOPUS-Indexed)
  • SC Peh, GG Gan, LK Lee, GI Eow.2008. Clinical relevance of CD10, BCL-6 and Multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia. Pathol Int ;58:572-79 (ISI-Indexed)
  • Sekaran ND, GG Gan, Kamarulzama A. 2008. Applying the multinational association for supportive care in cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients. Annals of Hematology; 87(7) :563-569 (ISI-Indexed)

2007
  • Sekaran ND, GG Gan, Kamaruzaman A, Sam J I. 2007. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical centre in Malaysia Int J Infect Dis. 11(6):513-7 (ISI-Indexed)
  • Parasubramaniam S, Karunakaran R, Gin GG, Muniandy S, Parasakthi N. 2007.Imipenem-resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction. Int J Infect Dis. 11(5):472-4 (ISI-Indexed)
  • Palasubramaniam S, Karunakaran R, Gin GG, Muniandy S, Parasakthi N. Imipenem resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction. Int J Infect Dis 2007 11:472-4 (ISI-Indexed)
  • PC Bee, GG Gan, AR Haris, Z Zakaria, Wan Ahmad WA.2007 Comparison of a portable device and standard Laboratory measured INR in the University Malaya Medical Centre. Asean Heart J;15:59-62 (Non-ISI/Non-SCOPUS)

2006
  • PC Bee, GG Gan, AKH Teh, AR Haris. \" The local experience of imatinib mesylate in the treatment of chronic myeloid leukemia\", 2006, medical journal of malaysia (SCOPUS-Indexed)
  • GG Gan, JF Pasagna, GI Eow, VS Nadarajah. , \"A Case report of chronic neutrophilic leukemia.\", 2006, Singapore Med J (ISI-Indexed)

2005
  • Gan Shiaw Sze @ Gan Gin Gin, CF Leong, JV Sangkar, Alan The, KY Goh , SK Cheong. \" The use of of mycophenolate mofetil in treating patients with non responding aplastic anemia. \", 2005, Med. J. Malaysia, Vol. 60, no. 3, pg. 311-13 (SCOPUS-Indexed)
  • A K H Shia, Gan Shiaw Sze @ Gan Gin GinS Jairaman, S- C Peh, "High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients. ", 2005, J. Clin. Pathol., Vol. 58, pg. 962-967 (ISI-Indexed)
  • B J J ABDULLAH, N MOHAMMAD, J V SANGKAR, Y F ABD AZIZ, G G GAN, K Y GOH, AND I BENEDICT INCIDENCE OF UPPER LIMB VENOUS THROMBOSIS ASSOCIATED WITH PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) BR J RADIOL 2005 78: 596-600 (ISI-Indexed)

2004
  • Gan Shiaw Sze @ Gan Gin Gin, CS Ku, Phipps M, JV Sangkar, Teh A., \" Genetic polymorphism in warfarin maintenance doses\", 2004, Vol. 80, pg. 295-6 (ISI-Indexed)
  • PC Bee, GG Gan, JV Sangkar, Teh A, KY Goh. A case of T- cell acute lymphoblastic leukemia after treatment of acute promyelocytic leukemia. Int J Hematol. 2004;79:358-60 (ISI-Indexed)
  • GG Gan, GI Eow, AKH Teh, SC Ng, JV Sangkar. Familial Hemaphagocytic lymphohistiocytosis in two brothers. Medical J Malaysia 2004;59(1):100-2 (SCOPUS-Indexed)

2003
  • KP Ng, Soo-Hoo TS, SL Na, GG Gan, JV Sangkar. 2003. Scopuloriopsis brevicaulis in a leukemia patient . Med J Malaysia ;58(4): 608-612 (SCOPUS-Indexed)
  • GG Gan, Teh A, KY Goh, HT Chong, KW Pang.2003 Racial background is one of the determinant factors in the maintenance dosage of warfarin. International Journal of Hematology ;78: 84-86 (ISI-Indexed)
  • Kim yen Goh, Gan Shiaw Sze @ Gan Gin Gin,JV Sangkar, R Puthashanan, M Norhafiza, Teh A. "Treatment of chronic myeloid leukemia patients with imatinib mesylate-the UMMC experience.", 2003, Med. J. Malaysia, Vol. 58, no. suppl, pg. 92-93 (SCOPUS-Indexed)
  • CS Ku, GG Gan, JV Sangkar, Phipps M. Frequency of cytochrome P4502C9 (CYP2C9) alleles in a Malaysian population. Asia Pacific Journal of Molecular Biology and Biotechnology 2003 ;11(2): 83-91 (SCOPUS-Indexed)

2002
  • Gan G G, Kamarulzaman A, Goh KY, Ng KP, Na SL, Soo-Hoo TS. 2002. Non-sporulating Chrysosporium: An opportunistic fungal infection in a neutropenic patient. Med J Malaysia ;57(1) : 118-122 (SCOPUS-Indexed)
  • SC Peh, YC Tai, LH Kim, Jairaman S, SS Gan, HP Lin. 2002. The pattern of Burkitts s Lymphoma in Malaysian Patients. Journal of Clinical and Experimental Hematopathology ;42(2):67-73 (ISI-Indexed)
Proceeding

2015
  • GG Gan, YC Leong, D Ng, PC Bee, E Chin, AKH Teh.Anxiety and depression in patients with haematological cancers in Malaysia.The XIIth Malaysian National Haematology Scientific Meeting 2015, (Non-ISI/Non-SCOPUS)
  • DLC Ng, GG Gan, YC Leong. Quality of life among lymphoma survivors in developing country. Annals of Oncology 2015; 26(suppl 9):85-92. Doi:10.1093/annonc/mdv526.20 (ISI-Indexed)
  • 44. CL Wong, G Gerrad, ZA Norziha, NR Tumian, SK Cheong, CF Leong, PC Bee, GG Gan, J Sathar, B Ma, L Liang, L Foroni, T Aitman, M Laffan. JAK2 V617F mutation in combination of ASXL1, DNMT3, TET2, U2AF1 and RUNX1 variants is associated with severe clinical phenotypes in primary myelofibrosis. Haematologica 2015 ; 100 (suppl 1):531 (ISI-Indexed)

2014
  • Norashikin Saidon, PC Bee, GG Gan. Beliefs in iron chelation therapy among adult transfusion dependent thalassemia patients in University Malaya Medical Centre. The XIth Malaysian National Haematology Scientific Meeting 2014, Kuala Lumpur , Malaysia . April 2014 
  • GG Gan, HL Lee, PC Bee. E Chin, CG Ng. Complementary and alternative medicine use in patients with haematological malignancies in UMMC. The XIth Malaysian National Haematology Scientific Meeting 2014, Kuala Lumpur , Malaysia . April 2014, page 63 (Non-ISI/Non-SCOPUS)
  • GG Gan, DLC Ng, YC Leong. Quality of life in patients with haematological cancers at university Malaya Medical Center. The XIth Malaysian National Haematology Scientific Meeting 2014, Kuala Lumpur , Malaysia . April 2014,pg64 

2013
  • The epidemiology of invasive fungal infection in patients with haematological diseases in a tertiary centre in Malaysia Ting SK, Gan GG Bee PC1 , Chin E , , Habibah MAH , Na SL, Ng KP , 
  • Ethnic variation in Interleukin-6 -174G/C polymorphism in Malaysian Population Gan GG, Subramaniam R, Lian LH, Nadarajan VS 
  • Ethnic variation in Interleukin-6 -174G/C polymorphism in Malaysian Population Gan GG, Subramaniam R, Lian LH, Nadarajan VS 

2010
  • H Abdul Halim, GG Gan , KP Ng, MHF Abdul Rahman, E Chin, N Abdul Latiff, WC Su,MC Mok. Retrospective study of positive fungal blood cultures in University Malaya Medical centre: clinical relevance and outcome revisited. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010,pg 86 (Non-ISI/Non-SCOPUS)
  • PC Bee, GG Gan, Haris AR, E Chin. The Influence of Ethnicity upon Quality of Life after Haematopoietic Stem Cell Transplantation in a Teaching Hospital in Malaysia. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010 (Non-ISI/Non-SCOPUS)
  • PC Bee, GG Gan, Haris AR, E Chin. Appetite loss is an independent adverse factor for poorer Quality of Life after Haematopoietic Stem Cell Transplantation in a Teaching Hospital in Malaysia. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010, pg81 (Non-ISI/Non-SCOPUS)
  • PC Bee, GG Gan Ting TY, Haris AR, E Chin, Habibah AH, Nadarajan VS. An Update on Imatinib Mesylate Therapy in Chronic Myeloid Leukaemia Patients in a Teaching Hospital in Malaysia. First Asean federation of Haematology and 8th National haematology ,pg 80 scientific meeting, April 2010,pg 80 (Non-ISI/Non-SCOPUS)
  • GG Gan, Subramaniam R, Nadarajan VS, Haris AR, PC Bee, E Chin, Habibah AH. Cytokine gene polymorphism and acute graft versus host disease in allogeneic stem cell transplantation.First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010,pg 84 (Non-ISI/Non-SCOPUS)
  • GG Gan, Subramaniam R, Nadarajan V. Cytokine gene frequency in Malaysian population. 8th National haematology scientific meeting, April 2010; pg86 (Non-ISI/Non-SCOPUS)
  • Norfaizal L, GG Gan, Bee PC, Haris AR, E Chin, Habibah AH. Autologous peripheral blood stem cell harvesting: factors that influence the yield of stem cells. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010, pg 85 (Non-ISI/Non-SCOPUS)
  • Norfaizal L, GG Gan, Bee PC, Haris AR, E Chin, Habibah AH. A pilot study to look at the effect of helicobacter pylori eradication in adults with immune thrombocytopenia purpura at UMMC. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010,p83 (Non-ISI/Non-SCOPUS)
  • Phan CL, Ang CH, Liang KL, Gan GG, Zubaidah Z, Nadarajah VS. Identification of unbalanced genomic abberations by array CGH in chronic myeloid leukemia patients with suboptimal response to imatinib treatment. First Asean Federation of Haematology and 8th National haematology scientific meeting,p121 (Non-ISI/Non-SCOPUS)
  • Nadarajah VS, Subramanian R, GG Gan. The IL-12 \'3UTR (-1188A/C) polymorphism is associated with survival outcome of hematopoeitic stem cell transplants. First Asean Federation of Haematology and 8th National Hameatology scientific meeting, pg 102 (Non-ISI/Non-SCOPUS)

2008
  • GG Gan, ME Phipps, TA Jinam, RH Abdul Rahman, PC Bee. VKORC1 gene polymorphism is responsible for interethnic variation of warfarin dose. 7th National Haematology scientific Meeting., April 2008, p61 
  • PC Bee, Haris AR, JV Sangkar, E Chin, GG Gan. A rare presentation of multiple myeloma: multiple cranial nerves lesions secondary to intracranial plasmacytoma. 7th National Haematology scientific Meeting., April 2008, p69 (Non-ISI/Non-SCOPUS)
  • PC Bee, L Ng, Sasheela, GG Gan. Infection in febrile neutropenia patients: antibiotic usage , microbiology and antibiotic resistance pattern. 7th National Haematology scientific Meeting., April 2008, p67 (Non-ISI/Non-SCOPUS)
  • PC Bee, GG Gan, Jv Sangkar. Haris Rahman, E Chin. Quality of Life after stem cell transplantation. 7th National Haematology scientific Meeting., April 2008, p68 (Non-ISI/Non-SCOPUS)
  • 17. E Chin, GG Gan, PC Bee, Haris Rahman. A retrospective study of CHOP-like chemotherapy plus Rituximab compared with CHOP-like chemotherapy alone in patients with diffuse large B cell Lymphoma in UMMC. 7th National Haematology scientific Meeting., April 2008, p68 (Non-ISI/Non-SCOPUS)

2007
  • 16. Rafidah Mohamada, Gan Gin Ginb, Veera S Nadarajanc.Dendritic cells and cytokine levels as predictors of acute graft-versus-host disease in allogeneic stem cell transplantation. 24th World Congress of Pathology and Laboratory Medicine 2007. 20- 24th August (SCOPUS-Indexed)
  • Peh SC, Gan GG, Lee LK and Eow GI. The Antigen Expressions of BCL-2, BCL-6, CD10, CD138 and MUM-1 in Diffuse Large B-Cell Lymphomas: A Cohort Study. In, Proceedings: 24th World Congress of Pathology and Laboratory Medicine, Sunway Pyramid Convention Centre, Petaling Jaya, Selangor, 20 ¿ 24 August 2007. Abstract published in The Malaysian Journal of Pathology 2007; 29(Supp A): 170. (SCOPUS-Indexed)

2006
  • Zakaria MZ, Gan GG, Rahman HF, Bee PC. Treatment of refractory idiopathic thrombocytopenia purpura with the anti-CD20 monoclonal antibody Rituximab. 6th Malaysian National Haematology Scientific Meeting, April 2006. p95 (Non-ISI/Non-SCOPUS)
  • Zakaria MZ, Gan GG, Rahman HF, Bee PC. Teicoplanin- induced aplastic anemia. 6th Malaysian National Haematology Scientific Meeting, April 2006. p63 (Non-ISI/Non-SCOPUS)

2004
  • JV Sangkar, Kamarulzaman A, GG Gan, A Teh. Case Report: Candida Parapsilosis Cellulitis. . 5th Malaysian National Haematology Scientific Meeting, April 2004 p83 (Non-ISI/Non-SCOPUS)
  • GG Gan, S Wong, A Teh, KY Goh, JV Sangkar. Adult Allogeneic Hematopoetic Stem Cell Transplantation-UMMC experience. 5th Malaysian National Haematology Scientific Meeting, April 2004 p89 
  • GG Gan CC Kam, SC Peh, JV Sangkar. A Clinical report of Diffuse Large B cell Lymphoma in University Malaya Medical Centre. 5th Malaysian National Haematology Scientific Meeting, April 2004. p73 (Non-ISI/Non-SCOPUS)

2003
  • SS Gan, SC Ng , AKH Teh, KY Goh, VS Jaganathan, Low dose thalidomide as a treatment for relapsed/refractory multiple myeloma. 8Th Annual Congress of the European Hematology Association, June 2003 
  • SS Gan, CF Leong, VS Jaganathan, KY Goh, AKH Teh, SK Cheong, SC Ng. Mycophenolate mofetil and aplastic anemia. 8Th Annual Congress of the European Hematology Association, June 2003 

2000
  • Gan GG, Ng SC, Teh A, Eow GI. Drug induced agranulocytosis treated with hematopoietic growth factor ¿ A report of 11 patients. 42nd Annual Meeting of American Society of Hematology, San Francisco, California. Blood 2000; 96(11); p154b 
  • Ng SC, Gan GG. The development of autoimmune disease in immune thrombocytopenia purpura patients ¿ a long term follow up of 72 Asian patients. 42nd Annual meeting of American Society of Hematology. San Francisco, California, Blood 2000; 96 (11): p68b (ISI/SCOPUS Indexed Publication)
  • Goh KY, Teh A, Gan GG . BFM B cell protocol as salvage chemotherapy for relapsed and refractory high grade Non-Hodgkin Lymphoma B cell type. 28th World Congress of the International Society of Hematology, Toronto, Canada, August 2000. p91 
Others

2006
  • ZAKARIA MZ,GAN SHIAW SZE @ GAN GIN GIN, RAHMAN HF, BEE PC TREATMNET OF REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA WITH THE ANTICD20 MONOCLONAL ANTIBODY RITUXIMAB THE 6TH MALAYSIAN NATIONAL HAEMATOLOGY SCIENTIFIC MEETING 2006 
  • G G GAN, PC BEE, KL GOH, AR HARIS HELICOBACTER PYLORI AND IMMUNE THROMBOCYTOPENIA PURPURA THE 6TH MALAYSIAN NATIONAL HAEMATOLOGY SCIENTIFIC MEETING APRIL 2006 
  • ZAKARIA MZ, GAN GG, RAHMAN HF, BEE PC TEICOPLANIN-INDUCED APLASTIC ANEMIA 6TH MALAYSIAN NATIONAL HAEMATOLOGY SCIENTIFIC MEETING APRIL 2006 

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).


  • To determine the frequency of CYP2C19 genotypes in patients with coronary artery disease treated at our local centre and correlate to the clinical outcome of these patients., Consultant, 2017 - 2019, Bantuan Kecil Penyelidikan (BKP), (National)
  • Frequency of CYP2C9 genotypes in patient with coronary artery disease treated at our local centre and correlate with clinical outcomes, Co-Investigator, 2017 - 2018, Bantuan Kecil Penyelidikan (BKP), (National)
  • microRNA expression (genetic testing) for early detection of diffuse large b cell lymphoma recurrences, Co-Investigator, 2017 - 2019, Private Funding, (International)
  • Phase 3 open label multicentre randomised y of ASP1125 versus salvage chemotherapy in patients with relapsed refractory acute myeloid leukemia with FLT 3 mutation, Principal Investigator(PI), 2017 - 2019, Private Funding, (International)
  • quality of life of family caregivers of cancer patients in Malaysia, Principal Investigator(PI), 2016 - 2018, Private Funding, (National)
  • Global Anticoagulant Registry in the FIELD observing treatment and outcomes in patients with treated acute Venous Thromboembolic Events in the real world 2015- current, Co-Investigator, 2015 - 2017, private industrial , (International)
  • 2.A randomized, double-blind, phase III study comparing Biosimilar Rituximab (RTXM83) plus CHOP chemotherapy versus Reference Rituximab plus CHOP (R-CHOP) in patients with Diffuse Large B-Cell Lymphoma (DLBCL) given as first line RTXM83-AC-01-11, Principal Investigator(PI), 2015 - 2015, Innogene , (International)
  • A single arm study of brentuximab vedotin in patients with relapsed and refractory Hodgkin lymphoma who are not suitable for stem cell transplantation or multiagent chemotherapy, Principal Investigator(PI), 2014 - 2016, takeda, (International)
  • A phase 3 randomized study of the efficacy and safety of posaconazole versus voriconazole for the treatment of invasive aspergillosis in adults and adolescents., Principal Investigator(PI), 2014 - 2015, , (International)
  • 5.A Randomized, Multicenter, Open-Label, Phase 3 Study of the Bruton s Tyrosine Kinase (BTK) Inhibitor PCI-32765 (Ibrutinib) versus Rituximab in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Principal Investigator(PI), 2014 - 2015, janseen, (International)
  • a retrospective analysis of safety,efficacy and cost of chemo-mobilization for patients planned to udnergo autologous-HCT, Co-Investigator, 2013 - 2014, , (International)
  • polymorphisms in DNA repair genes and risk of Non Hodgkin lymphoma, Co-Investigator, 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • CANCER AND ITS ECONOMIC IMPACT ON HOUSEHOLDS IN THE ASEAN COUNTRIES, Co-Investigator, 2012 - 2016, ROCHE educational grant, (National)
  • Interleukin 6 and 12 polymorphism is associate with poor outcome in haematopoeitic stem cell transplantation., Principal Investigator(PI), 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Molecular Genetic: Project 8. Genome Organization in Diseases: from Mutations to Structural Variations and Epigenetics, Co-Investigator, 2011 - 2015, High Impact Research (HIR), (National)
  • A PILOT STUDY TO DETERMINE IF ASSOCIATION OF CYTOKINE GENE POLYMORPHISM INFLUENCE THE RISK OF GRAFT VERSUS HOST DISEASE IN ALLOGENEIC HEMOTOPOIETIC STEM CELL TRANSPLANTATION, Principal Investigator(PI), 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • A Randomized, Double-Blind, Placebo-Controlled, Phase II study To Evaluate Efficacy And Safety of Deferasirox In Non-Transfusion-Dependent Thalassemia Patients With Iron Overload (THALASSA), Co-Investigator, 2009 - 2011, , (National)
  • A pilot study to determine if association of cytokine gene polymorphism influence the risk of graft versus host disease in allogeneic hematopoeitic stem cell transplantation, Principal Investigator(PI), 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • an international , multicenter randomised double blindstudy of vorinostat (MK0683) or placebo in combination with bortezomib in patients with multiple myeloma ( MK0683-088), Co-Investigator, 2008 - 2010, Merck, (International)
  • SERIAL IDENTIFICATION OF UNBALANCED GENOMIC ABERRATIONS BY ARRAY CGH IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB TREATMENT : CORRELATION WITH CORRESPONDING GENE EXPRESSION, MIRNA AND TREATMENT RESPONSE, Co-Investigator, 2008 - 2010, ScienceFund, (National)
  • A RANDOMISED, OPEN-LABEL, MULTICENTRE PHASE 3 STUDY OF THE COMBINATION OF RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VELCADE AND PREDNISONE (VcR-CAP) OR RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (R-CHOP) IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR A BONE MARROW TRANSPLANT., Principal Investigator(PI), 2008 - 2013, Johnson & Johnson Pharmaceutical Research & Development, (International)
  • a phase III double blinded randomised study to evaluate the safety and efficacy of BAL8557 versus voriconazole for primary treatment of invasive fungal disease caused by aspergillosis species or other filamentous fungi, Principal Investigator(PI), 2007 - 2010, basilea, (International)
  • Genetic polymorphisms of vitamin K epoxide reductase (VKORC), associated genes and warfarin dose variability in Malaysian Population., Principal Investigator(PI), 2007 - 2008, Fundamental Research Grant Scheme (FRGS), (National)
  • An open-label, multicenter, expanded access study of oral AMN 107 in adult patients with Imatinib (Glivec /Gleevec ) - resistant or - intolerant chronic myeloid leukemia in blast crisis, accelerated phase or chronic phase, Principal Investigator(PI), 2006 - 2008, Novartis, (International)
  • Association study of single nucleotide polymorphisms in selected candidate genes in NonHodgkin lymphoma in Malaysian population, Principal Investigator(PI), 2006 - 2008, ScienceFund, (National)
  • helicobacter pylori and immune thrombocytopenia purpura, Principal Investigator(PI), 2004 - 2005, Short Term Research Fund (Vote F)(PJP), (National)
  • clinical relevance of genetic polymorphism in human CYP2C9 subfamily and racial backgrounds in warfarin maintenance dose in Malaysia, Principal Investigator(PI), 2003 - 2004, Fundamental Research Grant Scheme (FRGS), (National)

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).


  • review standard for cord blood banking and transplantation, 2015-2015, ministry of health
  • national antibiotic guideline 2014, 2014-2014, KKM

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).


  • Bronze Award for Clinical Abstract, Malaysian Society of Haematology, 2018, (National)
  • Excellence Service Award, University Malaya, 2016, (University)
  • Outstanding Poster Award, Malaysian Society of Haematology, 2014, (National)
  • Excellence Service Award, University Malaya, 2013, (University)
  • Excellence Service Award, University Malaya, 2010, (University)
  • Best Poster, Malaysian Society of Haematology, 2008, (National)
  • Certificate of Excellent Service, University Malaya, 2005, (University)
  • Excellence Service Award, University Malaya, 2003, (University)
  • Young Investigator Stipend Award, Pan Pacific Lymphoma Conference, 2003, (International)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).


INVITED SPEAKER
  • managing difficult mobiliser, stem cell manipulation-durrent practice and expectations, transfusion medicine course, 2005-03-28 to 2005-04-01, (University)
  • transfusion support in neutropenic and immunocompromised, transfusion course, 2006-03-28 to 2006-03-30, (hospital)
  • emerging treatment options of myelodysplastic syndrome, 6th natioanl scientific meeting of malaysian society of haematology, 2006-04-22 to 2006-04-24, (National)
  • managing the transfusion dependent patients, transfusion course, 2007-03-12 to 2007-03-14, (hospital)
  • haematopoeitic stem cell transplantation in Malaysia, International Congress on bone marrow and stem cell transplantation, 2007-11-13 to 2007-11-15, (International)
  • epigenetics in cancer, MDS talk , 2009-03-17 to  
  • novel therapy for relapsed/refractory multiple myeloma, multiple myeloma, 2009-05-16 to  
  • diagnosis and treatment of invasive fungal disease in immunocompromsied patients, Malaysian Thoracic Society , 2009-07-25 to  , MTS, (National)
  • early complication of haematopoeitic stem cell transplantation, Ampang Hospital update- ABC of transplantation, 2009-08-15 to  , ampang hospital haematology department, (National)
  • is mesenchymal stem cells immunosuppressive?lesson learned from GVHD, advances in stem cell therapy, 2009-12-13 to  , (University)
  • genetic polymorphism and its impact on drug therapy, the 8th national haematology scientific meeting, 2010-04-24 to 2010-04-26, malaysian society if haematology, (National)
  • approach to haematology oncology emergencies, saturday teach in- haematology, 2011-01-08 to 2011-01-08, academy of medicine, (National)
  • management of MDs in the era of novel agents, the 9th Malaysian national haematology scientific meeting , 2011-04-30 to  , Malaysian soceity of haematology, (National)
  • the approach toa dult patients with thrombocytopenia , saturday teach in on hematology , 2012-05-12 to  , academy of medicine, malaysia, (National)
  • role of reduced intensity conditioning regimen for allogeneic stem cell transplantation, art of hematology, 2013-11-23 to 2013-11-25, MSH, SSH and sanofi , (National)
  • how i treat DLBCL-local perspective , Meet the expert session , 2015-07-11 to  , roche, (National)
  • how i treat low grade lymphoma , klang-ampang national hematology update , 2015-10-31 to  , KKM , (National)
  • high dose chemotherapy , mastercalss on systemic cancer therapy, 2017-03-04 to 2017-03-05, MOS, UMMC, (National)
  • clinical use of haematopoietic stem cell , national stem cell seminar, 2017-10-10 to 2017-10-10, MSCRT, UPM and NSCERT, (National)
  • updates on managemnt of DLBCL, updates on haematological neoplasm , 2017-12-09 to 2017-12-09, UM and MSH , (National)
  • high dose chemotherapy and stem cell rescue, MAsterclass in systemic chemotherapy , 2018-03-09 to 2018-03-10, malaysian Society of oncology and University Malaya, (University)
  • mangaement of relapsed refractory DLBCL, Malaysian Society of Haematology Annual Scientific Meeting , 2018-04-19 to 2018-04-21, Malaysian Society of Haematology, (National)
  • stem cell transplantation - its role in non haematological diseases and malignancies, 52nd Malaysia Singapore Congress of medicine , 2018-07-27 to 2018-07-29, Academy of Medicine Malaysia, Academy of Medicine Singapore, Hong Kong Academy of Medicine, (International)
PRESENTER
  • Ethnic variation in Interleukin-6 -174G/C polymorphism in malaysian population, Malaysian society of haematology Xth scientific meeting , 2013-04-26 to 2013-04-28
  • The epidemiology of invasive fungal infection in patients with haematological diseases in a tertiary centre in Malaysia, malaysian society of haematology xth scientific meeting , 2013-04-26 to 2013-04-28
  • JAK2 V617F mutation in combination of ASXL1, DNMT3, TET2, U2AF1 and RUNX1 variants is associated with severe clinical phenotypes in primary myelofibrosis., EHA 2015, 2015-12-01 to  
  • Quality of life among lymphoma survivors in developing country., ESMO Asia 2016 congress, 2015-12-01 to  
POSTER
  • Use of BFM B cell protocol as salvage chemotherapy for relapsed and refractory high grade Non Hodgkin Lymphoma B cell type The University Hospital Experience, between August 1997-December 1999., The 3rd National Conference of Haematology 2000, Kuala Lumpur, April 2000., 2000-04-10 to  , (National)
  • BFM B cell protocol as salvage chemotherapy for relapsed and refractory high grade Non-Hodgkin Lymphoma B cell type, 28th World Congress of the International Society of Hematology, 2000-05-27 to  , (International)
  • The development of autoimmune disease in immune thrombocytopenia purpura patients a long term follow up of 72 Asian patients., 42nd Annual meeting of American Society of Hematology. San Francisco, California, , 2000-12-04 to  , (International)
  • Drug induced agranulocytosis treated with hematopoietic growth factor A report of 11 patients., 42nd Annual Meeting of American Society of Hematology, San Francisco, California. Blood 2000, 2000-12-04 to  , (International)
  • The development of autoimmune disease in immune thrombocytopenia purpura patients a long term follow up of 72 Asian patients., 42nd Annual meeting of American Society of Hematology., 2000-12-08 to  
  • Bleeding tendency in a thrombophilia state, The 4th National conference of Hematology 2002, March 2002., 2002-03-20 to  , (National)
  • Bleeding tendency in a thrombophilia state., The 4th National conference of Hematology 2002,, 2002-04-12 to  , (National)
  • Low dose thalidomide as a treatment for relapsed/refractory multiple myeloma., 8Th Annual Congress of the European Hematology Association, 2003-01-01 to  
  • Mycophenolate mofetil and aplastic anemia., 8Th Annual Congress of the European Hematology Association, 2003-06-06 to  , (International)
  • Low dose thalidomide as a treatment for relapsed/refractory multiple myeloma. , 8Th Annual Congress of the European Hematology Association, June 2003 , 2003-06-25 to  , (International)
  • Mycophenolate mofetil and aplastic anemia. , 8Th Annual Congress of the European Hematology Association, June 2003 , 2003-06-25 to  , (International)
  • High dose therapy with autologous hematopoeitic stem cell transplantation in poor risk Non-Hodgkin Lymphoma- Malaysian Experience. , 2003 Pan Pacific Lymphoma Conference, 2003-07-15 to  , (International)
  • A Clinical report of Diffuse Large B cell Lymphoma in University Malaya Medical Centre., 5th Malaysian National Haematology Scientific Meeting,, 2004-04-09 to  , (National)
  • Adult Allogeneic Hematopoetic Stem Cell Transplantation-UMMC experience, 5th Malaysian National Haematology Scientific Meeting,, 2004-04-09 to  , (National)
  • Interdigitating Dendritic Cell Sarcoma, . 5th Malaysian National Haematology Scientific Meeting, April 2004., 2004-04-09 to  , (National)
  • A Clinical report of Diffuse Large B cell Lymphoma in University Malaya Medical Centre, 5th Malaysian National Haematology Scientific Meeting, 2004-04-16 to  
  • Adult Allogeneic Hematopoetic Stem Cell Transplantation-UMMC experience, 5th Malaysian National Haematology Scientific Meeting, 2004-04-16 to  , (National)
  • Case Report: Candida Parapsilosis Cellulitis. ., 5th Malaysian National Haematology Scientific Meeting, 2004-04-16 to  
  • Treatment of refractory idiopathic thrombocytopenia purpura with the anti-CD20 monoclonal antibody Rituximab, 6th Malaysian National Haematology Scientific Meeting, April 2006. , 2006-04-18 to  , (National)
  • Teicoplanin-induced aplastic anemia, 6th Malaysian National Haematology Scientific Meeting, , 2006-04-18 to  , (National)
  • Teicoplanin-induced aplastic anemia., 6th Malaysian National Haematology Scientific Meeting, 2006-04-21 to  , (National)
  • Treatment of refractory idiopathic thrombocytopenia purpura with the anti-CD20 monoclonal antibody Rituximab, 6th Malaysian National Haematology Scientific Meeting, 2006-04-21 to  , (National)
  • The Antigen Expressions of BCL-2, BCL-6, CD10, CD138 and MUM-1 in Diffuse Large B-Cell Lymphomas: A Cohort Study., 24th World Congress of Pathology and Laboratory Medicine, 2007-08-20 to  
  • Dendritic cells and cytokine levels as predictors of acute graft-versus-host disease in allogeneic stem cell transplantation, 24th World Congress of Pathology and Laboratory Medicine , 2007-08-20 to  
  • Dendritic cells and cytokine levels as predictors of acute graft-versus-host disease in allogeneic stem cell transplantation. , 24th World Congress of Pathology and Laboratory Medicine 2007, 2007-08-20 to 2007-08-24, (International)
  • The Antigen Expressions of BCL-2, BCL-6, CD10, CD138 and MUM-1 in Diffuse Large B-Cell Lymphomas: A Cohort Study. In, Proceedings, : 24th World Congress of Pathology and Laboratory Medicine,, 2007-08-24 to  , (International)
  • Infection in febrile neutropenia patients: antibiotic usage , microbiology and antibiotic resistance pattern., 7th National Haematology scientific Meeting.,, 2008-04-18 to  
  • Quality of Life after stem cell transplantation, 7th National Haematology scientific Meeting, 2008-04-18 to  
  • A rare presentation of multiple myeloma: multiple cranial nerves lesions secondary to intracranial plasmacytoma., 7th National Haematology scientific Meeting, 2008-04-18 to  
  • retrospective study of CHOP-like chemotherapy plus Rituximab compared with CHOP-like chemotherapy alone in patients with diffuse large B cell Lymphoma in UMMC., 7th National Haematology scientific Meeting., April 2008, 2008-04-25 to  
  • A retrospective study of CHOP-like chemotherapy plus Rituximab compared with CHOP-like chemotherapy alone in patients with diffuse large B cell Lymphoma in UMMC. , 7th National Haematology scientific Meeting, 2008-04-25 to  , (National)
  • Quality of Life after stem cell transplantation. , 7th National Haematology scientific Meeting, 2008-04-25 to  , (National)
  • rare presentation of multiple myeloma: multiple cranial nerves lesions secondary to intracranial plasmacytoma, National Haematology scientific Meeting., 2008-04-25 to  , (National)
  • VKORC1 gene polymorphism is responsible for interethnic variation of warfarin dose. 7th National Haematology scientific Meeting, 7th National Haematology scientific Meeting, 2008-04-25 to  
  • PC Bee, L Ng, Sasheela, GG Gan. Infection in febrile neutropenia patients: antibiotic usage, microbiology and antibiotic resistance pattern. April 2008, p67, 7th National Haematology scientific Meeting, 2008-04-25 to  , (National)
  • Cytokine gene frequency in Malaysian population., 8th National haematology scientific meeting, 2010-04-23 to  
  • Cytokine gene polymorphism and acute graft versus host disease in allogeneic stem cell transplantation., 8th National haematology scientific meeting, 2010-04-23 to  
  • An Update on Imatinib Mesylate Therapy in Chronic Myeloid Leukaemia Patients in a Teaching Hospital in Malaysia, 8th National haematology scientific meeting, , 2010-04-23 to  
  • Appetite loss is an independent adverse factor for poorer Quality of Life after Haematopoietic Stem Cell Transplantation in a Teaching Hospital in Malaysia., 8th National haematology scientific meeting, , 2010-04-23 to  
  • The IL-12 \'3UTR (-1188A/C) polymorphism is associated with survival outcome of hematopoeitic stem cell transplants, first Asean Federation of Haematology and 8th National haematology scientific meeting,, 2010-04-23 to  
  • Retrospective study of positive fungal blood cultures in University Malaya Medical centre: clinical relevance and outcome revisited., 8th National haematology scientific meeting, April 2010, 2010-04-23 to  
  • Autologous peripheral blood stem cell harvesting: factors that influence the yield of stem cells, First Asean Federation of Haematology and 8th National haematology scientific meeting,, 2010-04-23 to  
  • identification of unbalanced genomic abberations by array CGH in chronic myeloid leukemia patients with suboptimal response to imatinib treatment, First Asean Federation of Haematology and 8th National haematology scientific meeting,, 2010-04-23 to  
  • The Influence of Ethnicity upon Quality of Life after Haematopoietic Stem Cell Transplantation in a Teaching Hospital in Malaysia., 8th National haematology scientific meeting, April 2010, 2010-04-23 to  
EVENT ORGANISER
  • organising chairperson, the XI national scientific meeting of Malaysian Society of Haematology , 2014-04-04 to 2014-04-06, malaysian society of haematology , (National)
  • Clinical transfusion workshop , clinical transfusion workshop , 2015-08-21 to 2015-08-22, department of medicine, department transfusion medicine , malaysian society of hematology , (National)
  • updates on haematoloigcal neoplasm workshop , updates on haematoloigcal neoplasm workshop , 2017-12-09 to 2017-12-09, UM, MSH, (National)
  • updates on haematological neoplasms, updates on haematological neoplasms , 2018-11-03 to 2018-11-03, Faculty of Medicine, Department of Medicine, Department of Pathology, Malaysian Society of Haematology, (National)
OTHERS
  • bridging the gap of IFI management, evening symposium on IFI management, 2012-05-07 to  , MSD, MSH
  • myeloma and lymphoma , haematology updates 2014, 2014-08-23 to 2014-08-23, (National)
  • 12th Malaysian National Haematology Scientific Meeting 2015, 12th Malaysian National Haematology Scientific Meeting 2015, 2015-04-24 to 2015-04-25, (National)
  • thrombosis session , MSh2015 scientific meeting , 2015-04-24 to 2015-04-25, (National)
  • myeloma and AML, Art of heamatology , 2015-10-18 to  , (National)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).


  • MBBS phase3B faculty coordinator, University Malaya ,faculty of medicine, Coordinator, 2013-2015, (University)
  • training committee chairperson for clinical haematology, malaysian society of haematology, Chairman, 2012-2015, (National)
  • curriculum restructuring for MBBS for haematology, University Malaya, Advisor, 2011-2013, (University)

EVALUATION ACTIVITIES
(Description), (Evaluation Activity),(Year).


  • MASTER OF MEDICAL SCIENCE (RESEARCH MODE)- internal examiner MD MIRAZUL ISLAM (BANGLADESH) (MGN140042) title Cytokines and Chemokines Profiling of Adult Malaysian Acute Myeloid Leukemia (AML) Patients and Analysis of Molecular Abnormalities, Thesis ,  (2017 - 2017)
  • instituting robust in house karyotyping as part of standard diagnostic and management for children with acute lymphoblastic leukemia, Thesis ,  (2013 - 2013)
  • identification of unbalanced genomic abberations by array CGH in patient with chronic myeloid leukemia on imtinib treatment, Thesis ,  (2012)
  • clinical haematology exit exmainer, Clinical Haematology Exit Exam ,  (2012)
  • master of medical science-- thesis : quantitative RT-PCR analysis of wilms tumour 1 (WT1) gene for minimal residual disease monitoring in childhood acute myeloid leukemia, Thesis ,  (2011)
  • examiner for clinical haematology exit examination, Malasysian Society Of Haematology ,  (2010)
  • malaysian society of haematology 7th national scientific meeting, Abstracts ,  (2010)
  • master of medical science thesis-- P16 tumour suppressor gene in diffuse large b cell lymphoma, Thesis ,  (2009)
  • national standards for cord blood banking and transplantation -- ministry of health, Book ,  (2007 - 2008)
  • national organ , tissue and cell transplantation policy under ministry of health malaysia, Book ,  (2006 - 2007)
  • examiner for long case and short case and OSPE for MBBS phase 3A, phase 3B and Master of internal medicine stage 1 and 2, Mbbs Exam And Master Of Internal Medicine ,  (2001)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).


  • speaker for nursing seminar 5/2018 -hematologi, (hospital), 02/05/2018 until 02/05/2018
  • speaker for Malaysian Society of haematology annual scientifuc meeting , (National), 19/04/2018 until 19/04/2018
  • invited speaker for masterclass in systemic chemotherapy, (Local), 10/03/2018 until 10/03/2018
  • organizing chairperson for workshop on updates on haeamtological neoplasm, (Local), 09/12/2017 until 09/12/2017
  • speaker for updates on haematoligcal neoplasm, (Local), 09/12/2017 until 09/12/2017
  • speaker for national stem cell seminar, (National), 10/10/2017 until 10/10/2017
  • speaker for masterclass systemic cancer therapy , (Local), 05/03/2017 until 05/03/2017
  • committee member for MSH 2015 meeting , (National), 24/04/2015 until 25/04/2015
  • council member Malaysian society of haematology , (National), 01/04/2015 until 30/04/2018
  • subcommittee for NSR clincial hematology , (National), 04/01/2015 until 04/01/2016
  • speaker for art of hematology, (National), 23/11/2014 until 24/11/2014
  • KKM ahli jawatan kuasa kerja ubat hematologi , (Government), 01/06/2014 until 31/12/2017
  • chairperson for MSH invasive fungal infection forum , (National), 16/03/2013 until  
  • speaker for meet the trainees at haematology upate 2013, (National), 23/02/2013 until 23/02/2013
  • invited panel member for fungal infection advisory board , (International), 16/12/2012 until  
  • ASEAN FEDERATION OF HAEMATOLOGY -- Chairperson for one session , (International), 08/09/2012 until  
  • invited speaker for seminar oncology for nurses , (Local), 04/09/2012 until  
  • saturday teach in for hematology , (National), 12/05/2012 until  
  • chairperson for evening symposium for IFI , (Local), 07/05/2012 until  
  • training committee for clinical haematology -MSH 2012-2015, (National), 24/04/2012 until 31/03/2015
  • speaker for MSH2012 mini summitt, (National), 20/04/2012 until  
  • training committee for MSH clincial hematology , (National), 01/04/2012 until 30/04/2018
  • Malaysian Society of Haematology--council member, (National), 17/05/2008 until 25/04/2012
  • 7th national scientific meeting for MSH-secretary organising, (National), 10/04/2008 until 12/04/2008
  • Consensus guidelines for the management of Extended Spectrum Beta- Lactamases producing organisms. Academy of Medicine/Malaysian Society of infectious Disease and chemotherapy. 2001& 2007, (National), 01/01/2007 until 30/12/2007
  • working group member for the national standards for cord blood banking and transplantation, (National), 01/01/2007 until 01/01/2008
  • working group members for National Organ, Tissue and cell transplantation policy Ministry of Health 2007, (National), 01/01/2006 until 01/01/2007
  • Malaysian Society of Haematology-- secretary, (National), 17/04/2004 until 19/05/2008
  • 5th national haematology scientificn meeting- orgnansiign secretary, (National), 09/04/2004 until 11/04/2004

SUPERVISION


POST GRADUATE STUDENT
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Completed
  • Doctoral Degree (phd), Sujatha A/p Suthandiram, Molecular Analysis of Various Candidate Genes with Lymphoproliferative Disorders (LPDs) and Association with Methotrexate Related Toxicities and Serum Concentrations in Adult Multiethnic Population., 2014/2015
  • Doctoral Degree (phd), Sujatha A/p Suthandiram, Molecular Analysis of Various Candidate Genes with Lymphoproliferative Disorders (LPDs) and Association with Methotrexate Related Toxicities and Serum Concentrations in Adult Multiethnic Population., 2014/2015
  • Doctoral Degree (phd), Sujatha A/p Suthandiram, Molecular Analysis of Various Candidate Genes with Lymphoproliferative Disorders (LPDs) and Association with Methotrexate Related Toxicities and Serum Concentrations in Adult Multiethnic Population., 2014/2015
  • Doctoral Degree (phd), Henning Loo, erectile dysfunction among male haematological patients in UMMC, 2014/2015
  • Master Degree, Diana Ng, Quality of life in lymhoma patients, 2014/2015
  • Doctoral Degree (phd), Tengku Hidayat Tengku Ahmad, treatment outcome of multiple myeloma patients in UMMC, 2013/2014
  • Master Degree, Goh Kian Guan, -, 2012/2013
  • Master Degree, Mohd Faizal Abdul Latiff, autologous peripheral blood stem cell collection:factors that influences the yield of stem cells, 2009/2010
  • Master Degree, Tan Mei Chee, Association study of single nulceotide polymorphisms in selected candidate genes and non-hodgkin lymphoma in Malaysian populations, 2008/2009
  • Master Degree, Bee Ping Chong, Chronic Myeloid Leukemia and imatinib, 2004/2005
  • Master Degree, Ku Chee Seng, Master of Medical Science/pharmacogenetics of inter-ethnics variation in warfarin sensitivity using candidategene and genomic wide approach
  • Master Degree, Zanapiah Zakaria, haematologi/acute graft versus host disease after allogeneic hematopoieetic stem cell transplantation:analsyis of risk factors
  • Master Degree, Edmund Chin, haematologi/a retrospective study of CHOP like chemotherapy plus rituximab compared with CHOP like chemotherapy alone in patients with diffuse large B cell lymphoma in UMMC
  • Master Degree, Nirmala Devi Baskaran, Febrile neutropenia in hematology oncology-UMMC experience

Ongoing
  • Doctoral Degree (phd), Ting Choo Yuen, molecular genetics on haematological malignancies, 2018/2019
  • Master Degree, Ong Wan Feng, Master of internal medicin, 2017/2018
  • Master Degree, Cheng Shian Feng, Master of internal medicine, 2017/2018
  • Master Degree, Suganthi A/p Ramadas, Master of internal medicine, 2017/2018
  • Master Degree, Ong Wan Feng, -, 2016/2017
  • Master Degree, Ong Wan Feng, -, 2016/2017
  • Master Degree, Ong Wan Feng, -, 2016/2017
  • Master Degree, Henning Loo Cheng Kien, quality of life analysis in patients after haeatopoietic stem cell transplantation in UMMC, 2011/2012
  • Master Degree, Ting Seng Kiat, a study of invasive fungal infections in haematological patients in UMMC, 2011/2012
  • Doctoral Degree (phd), Sujatha A/p Suthandiram, genes involved in lymphoproliferative and association with methotrexate related toxicity in Malaysian population, 2010/2011

TEACHING
(Course Title), (Academic Session), (No of Student), (No of Contact Hours).


POST GRADUATE
  • MMed, 2014/2015, 15, 212
  • MMed, 2013/2014(1,2,3), 10, 102
  • MMed, 2012/2013, 20, 300
  • MMed, 2012/2013, 20, 8
  • MMed, 2012/2013, 20, 8
  • MMed, 2012/2013, 20, 8
  • master of medicine, 2010/2011, 10, 108
  • master of medicine, 2009/2010, 10, 108
  • master of medicine, 2008/2009, 10, 108
  • master of medicine, 2007/2008, 10, 108
  • master of medicine, 2006/2007, 10, 108
  • master of medicine, 2005/2006, 10, 108
  • master of medicine, 2005/2006, 10, 108
  • master of medicine, 2004/2005, 10, 108
  • master of medicine, 2004/2005, 10, 108
FIRST DEGREE
  • MBBS, 2015/2016(1,2), 6, 112
  • MBBS, 2014/2015(1,2,3), 10, 214
  • MBBS, 2013/2014(1,2,3), 6, 156
  • MBBS phase 3B , 2012/2013, 70, 25
  • MBBS phase 3 A, 2012/2013(1,2,3), 200, 4
  • MBBS phase 3B , 2012/2013, 70, 25
  • MBBS pahse 3B, 2011/2012, 40, 100
  • MBBS phase 3A, 2011/2012, 40, 8
  • MBBS phase 3A, 2011/2012, 40, 8
  • MBBS, 2011/2012, 8, 8
  • MBBS phase 3A, 2010/2011, 20, 42
  • MBBS phase 3B, 2010/2011, 100, 136
  • MBBS phase 2, 2009/2010, 25, 36
  • MBBS phase 3A, 2009/2010, 20, 42
  • MBBS phase 3B, 2009/2010, 100, 136
  • MBBS phase 2, 2008/2009, 25, 36
  • MBBS phase 3B, 2008/2009, 100, 136
  • MBBS phase 3A, 2008/2009, 20, 42
  • MBBS phase 2, 2007/2008, 25, 36
  • MBBS phase 3A, 2007/2008, 20, 42
  • dental , 2006/2007, 100, 2
  • MBBS phase 3B, 2006/2007, 100, 136
  • MBBS phase 3a, 2005/2006, 20, 272
  • MBBS phase 3a, 2004/2005, 20, 272
  • MBBS phase 3a, 2003/2004, 20, 272
  • dental , 2002/2003, 10, 20
  • MBBS phase 3a, 2002/2003, 20, 272
  • dental , 2001/2002, 10, 20
  • MBBS phase 3a, 2001/2002, 20, 272
  • dental , 2000/2001, 10, 20